搜尋結果
Will Roche Stock Rebound To Its 2022 Highs Of $50?
Forbes· 5 日前In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over this period ...
The 10 Best Performing Stocks So Far In 2024
Forbes· 7 日前The stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June ...